Early research (Phase 1)Active Not RecruitingNCT05217641
What this trial is testing
A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 108